← Evidence map

TrialOpen forum infectious diseases2026

Risk of Developing Low-Level Viral Rebound Among People With HIV Receiving 2- or 3-Drug Regimens: A Case-Control Study Nested in the ICONA Cohort.

Alessandra Vergori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Risk of Developing Low-Level Viral Rebound Among People With HIV Receiving 2- or 3-Drug Regimens: A Case-Control Study Nested in the ICONA Cohort. | OpenQuestion